Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Egetis Therapeutics AB (publ)

EGTX
Current price
5.53 SEK +0.33 SEK (+6.35%)
Last closed 5.18 SEK
ISIN SE0003815604
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 1 802 916 412 SEK
Yield for 12 month +10.60 %
1Y
3Y
5Y
10Y
15Y
EGTX
21.11.2021 - 28.11.2021

Egetis Therapeutics AB (publ), a pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a highly debilitating rare disease with no available treatment. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden. Address: Klara Norra Kyrkogata 26, Stockholm, Sweden, 111 22

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

137.62 SEK

P/E ratio

Dividend Yield

Current Year

+58 399 697 SEK

Last Year

+22 812 385 SEK

Current Quarter

+14 092 982 SEK

Last Quarter

+12 267 996 SEK

Current Year

-128 560 449 SEK

Last Year

-121 767 423 SEK

Current Quarter

+10 949 940 SEK

Last Quarter

+9 733 287 SEK

Key Figures EGTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -303 759 540 SEK
Operating Margin TTM -861.7 %
PE Ratio
Return On Assets TTM -34.1 %
PEG Ratio
Return On Equity TTM -81.32 %
Wall Street Target Price 137.62 SEK
Revenue TTM 68 944 089 SEK
Book Value 1.1 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -23 %
Dividend Yield
Gross Profit TTM -121 666 039 SEK
Earnings per share -1.22 SEK
Diluted Eps TTM -1.22 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EGTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EGTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation EGTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 8.7796
Enterprise Value Revenue 22.9192
Price Sales TTM 26.1504
Enterprise Value EBITDA -7.5641
Price Book MRQ 4.25

Financials EGTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EGTX

For 52 weeks

4.1 SEK 9.43 SEK
50 Day MA 4.79 SEK
Shares Short Prior Month
200 Day MA 5.99 SEK
Short Ratio
Shares Short
Short Percent